Rybelsus®
Rybelsus comprimidos (semaglutide) é um medicamento de prescrição utilizado em adultos com diabetes mellitus tipo 2 para diminuir os níveis de açúcar no sangue. O Rybelsus pode ser prescrito quando outros medicamentos para a diabetes foram experimentados sem sucesso e devem ser utilizados em conjunto com dieta e Exercício. Os comprimidos de Rybelsus actuam para reduzir os níveis de açúcar no sangue (glucose), aumentando a quantidade de insulina libertada e diminuindo a secreção de gl
Active Ingredient: semaglutide
Availability: In Stock (102 packages)
Rybelsus®, 3mg
| Pacote | Per Pack | Ordem | |
|---|---|---|---|
| 10 tablet x 3mg | €19.22 | €192.15 | |
20 tablet x 3mg
Free airmail shipping |
€17.30 |
|
|
30 tablet x 3mg
Free airmail shipping |
€16.34 |
|
|
60 tablet x 3mg
Free airmail shipping |
€15.38 |
|
|
90 tablet x 3mg
Free airmail shipping |
€14.41 |
|
Rybelsus®, 7mg
| Pacote | Per Pack | Ordem | |
|---|---|---|---|
| 10 tablet x 7mg | €19.22 | €192.15 | |
20 tablet x 7mg
Free airmail shipping |
€18.74 |
|
|
30 tablet x 7mg
Free airmail shipping |
€18.26 |
|
|
60 tablet x 7mg
Free airmail shipping |
€17.78 |
|
Rybelsus®, 14mg
| Pacote | Per Pack | Ordem | |
|---|---|---|---|
10 tablet x 14mg
Free airmail shipping |
€23.06 | €230.59 | |
20 tablet x 14mg
Free airmail shipping |
€22.10 |
|
|
30 tablet x 14mg
Free airmail shipping |
€21.62 |
|
|
60 tablet x 14mg
Free airmail shipping |
€21.14 |
|
Descrição do produto
Packaging
Rybelsus® (Semaglutide)
Rybelsus® tablets
What is Rybelsus?
Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.
Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.
Warnings
You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.
Packaging info
This is how your parcel will look like, the images are photographs of real shipments.
It has the size of a normal protected envelope and it does not disclose its contents.
